
Related News
-
Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says
Benzinga - 4:19 PM ET 2/25/2025
-
US Equities Markets End Mixed Tuesday as Consumer Confidence Drops More Than Expected
MT Newswires - 4:01 PM ET 2/25/2025
-
Nasdaq, S&P 500 Fall Tuesday as Diminished Consumer Confidence Sparks Downturn Worries
MT Newswires - 3:47 PM ET 2/25/2025
-
Nebius Challenges Hyperscalers With Dedicated AI Computing Services, Transparent Pricing: Analyst
Benzinga - 2:46 PM ET 2/25/2025
-
Benzinga - 2:22 PM ET 2/25/2025
-
Top 3 Materials Stocks That May Keep You Up At Night In February
Benzinga - 2:15 PM ET 2/25/2025
-
Home Depot Posts First Earnings Growth In 2 Years: Shares Up Despite Disappointing Guidance
Benzinga - 1:49 PM ET 2/25/2025